go back

Idecabtagene Vicleucel (Abecma), up to 460 Million Cells

Kentucky rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $52,481 · 10th–90th $41,687$56,2340%20%40%10th90th$52,481Professionalmedian $426,580 · 10th–90th $46,774$426,5800%50%10th$426,580$50.0K$100.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
CareSource
Setting
Facility
Modifier
Global
Typical Low
$41,686.94
Median
$52,480.75
Typical High
$56,234.13
CareSource
Setting
Professional
Modifier
Global
Typical Low
$46,773.51
Median
$426,579.52
Typical High
$426,579.52